UT Health San Antonio researcher awarded five-year, $2.53 million NIH grant to study alcohol-assisted liver disease
Liver transplants associated with alcohol-related disease are growing at a rapid pace, shifting research to address pathologies behind the ailments in light of a limited supply of organ donors.
At the forefront is Mengwei Zang, MD, PhD, an internationally recognized leader in chronic liver disease research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) who was just awarded a groundbreaking five-year, $2.53 million grant from the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
Zang, professor at the university’s Sam and Ann Barshop Institute for Longevity and Aging Studies and the Department of Molecular Medicine at the Joe R. and Teresa Lozano Long School of Medicine, will use the funding to develop innovative approaches to investigate the pathological mechanisms underlying alcohol-associated liver disease.
Learn more about Dr. Zang’s research:
